U.S. Online Retail and Ecommerce Stock News

Forward Air is set to report its Q1 2026 results, with Wall Street expecting a loss of US$0.37 per share on about US$620.20 million in revenue, as the company continues to work through operational integration challenges. Investor attention is now centered on how management’s update on operating ratios, segment margins, and profitability timelines might signal tangible progress in integrating recent acquisitions. Now we’ll examine how expectations for improved integration and profitability...

If you are wondering whether PayPal Holdings at around US$50 per share is a bargain or a value trap, the key is to look closely at what the current price implies about its future. The stock recently closed at US$50.39, with returns of 1.2% over the last week and 11.1% over the last month, while the year to date return stands at a 13.3% decline and the one year return at a 26.1% decline. Recent coverage has focused on PayPal's position in digital payments and how competitive pressures and...

If you are wondering whether Equifax stock offers value at its current price, or if it is still pricing in too much past optimism, this article breaks down what the numbers are actually saying. The stock last closed at US$172.24, with returns of 1.0% over the past week, a 5.6% decline over the past month, and year to date and 1 year returns of 19.5% and 33.8% declines respectively. These figures may affect how you think about both risk and potential reward. Recent headlines around Equifax...

Earnings reversal puts Stepan’s latest quarter in focus Stepan (SCL) is back on investors’ radar after first quarter 2026 results showed sales of US$604.51 million alongside a net loss of US$41.41 million, compared with net income a year earlier. See our latest analysis for Stepan. The shares have softened around the earnings release, with a 1-day share price return of a 1.55% decline and a 7-day share price return of a 3.55% decline. The 1-year total shareholder return of a 2.19% decline and...

Wondering whether Plains GP Holdings is still reasonably priced after its strong run, or if expectations have gone too far? This breakdown will help you frame the stock's current value against its fundamentals. The stock last closed at US$24.23, with returns of 3.6% over 7 days, 0.7% over 30 days, 24.8% year to date and 52.0% over the past year, plus 128.0% over 3 years and 247.1% over 5 years. Recent coverage has focused on Plains GP Holdings as an established player in the midstream energy...

Wondering if Teva Pharmaceutical Industries at around US$35.35 is still offering value or if most of the opportunity has already been reflected in the price? This article breaks down what the current valuation signals are really saying. The stock has posted returns of 13.1% over the past week, 17.5% over the last month, 14.2% year to date and 115.7% over the past year, with a very large 3 year gain and a 244.9% 5 year return that naturally raise questions about risk and reward at today’s...

Compass (NYSE:COMP) agreed to acquire a 51% controlling stake in a venture, expanding its influence over a key part of its residential real estate platform. The company also entered a three year alliance with Rocket to broaden its home listing inventory and give agents access to a wider set of buyer and seller opportunities. At the same time, Compass continues to face federal price fixing litigation that introduces ongoing legal and operational uncertainty for the business. Compass focuses...

H2O America stock: overview and recent performance H2O America (HTO) has drawn fresh attention after its recent name change from SJW Group in May 2025. This has prompted investors to reassess how the stock’s returns and fundamentals stack up today. The utility provider, focused on water and related services in the United States, recently closed at $57.32. Over the past month the stock shows a return of a 3.1% decline, while the past 3 months reflect an 8.8% gain and the year-to-date figure...

This article looks at whether Novavax, trading at around US$8.03, is attractively priced or potentially a value trap, by exploring what the current price may be implying about the stock. The stock has seen mixed returns, with a 0.5% decline over the last 7 days, a 4.3% gain over 30 days, 12.6% year to date, 28.1% over 1 year, 7.8% over 3 years and a 95.0% loss over 5 years. Recent headlines around Novavax have kept the stock in focus, particularly as investors reassess its prospects beyond...

The United States market remained flat over the last week, yet it has seen a significant rise of 28% over the past year, with earnings expected to grow by 16% annually. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and robust financial health to capitalize on these favorable conditions.

Over the last 7 days, the United States market has remained flat, yet it has seen a significant rise of 28% over the past year, with earnings projected to grow by 16% annually in the coming years. In such an environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervaluation.

The United States market remained flat over the last week, yet it has experienced a significant 28% rise over the past 12 months with earnings projected to grow by 16% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.

The market remained flat over the last week, though it has risen 28% over the past year with earnings expected to grow by 16% annually. For investors willing to explore beyond well-known names, penny stocks—often representing smaller or newer companies—can still offer surprising value and potential for growth. In this article, we examine three penny stocks that combine financial strength with promising prospects in today's evolving market landscape.

Over the last 7 days, the United States market has remained flat, yet it is up 28% over the past year with earnings forecasted to grow by 16% annually. In this dynamic environment, identifying stocks that are not only resilient but also poised for growth can uncover potential opportunities in lesser-known companies.

Trevi Therapeutics recently announced plans to present detailed Phase 2b CORAL trial results and additional nalbuphine ER data for IPF-related chronic cough at the ATS 2026 International Conference in Orlando on May 18, 2026. Alongside upcoming Q1 2026 results and a proposal to double authorized common shares, these scientific disclosures highlight how clinical and corporate actions may shape Trevi’s future options for funding and advancing Haduvio. We’ll now examine how the upcoming Phase...

Eve Holding, Inc. has reported first quarter 2026 results, recording a net loss of US$68.81 million, higher than the US$48.78 million loss in the same period last year. This widening loss underlines the financial strain of Eve’s ongoing eVTOL development phase and raises fresh questions about how its cash resources will support the path to commercialization. We’ll now explore how this larger quarterly net loss may influence Eve Holding’s investment narrative built around future urban air...

Innoviva’s Shelf Registration and What It Could Mean for Shareholders Innoviva (INVA) has filed a shelf registration to potentially offer up to US$207.99 million of common stock, covering 9,000,000 shares in an ESOP related transaction that could influence future valuation. See our latest analysis for Innoviva. Against the backdrop of this shelf registration and a fresh equity incentive plan, Innoviva’s recent share price return has been mixed in the very short term, but supported by stronger...

In late April 2026, Schneider National, Inc. reported first‑quarter results showing mostly flat revenue at US$1,398.5 million and lower net income of US$20.4 million year on year, while also completing a US$5.21 million share repurchase, affirming a US$0.10 quarterly dividend, and updating its bylaws to strengthen the role of the lead independent director in board leadership and succession. An interesting angle is that Schneider paired an earnings-per-share beat relative to analyst...

Recent commentary around Edgewell Personal Care (EPC) has focused on weaker organic revenue, falling productivity and lower operating margins, alongside a high net-debt-to-EBITDA ratio that has put potential dilution risk on investor radar. See our latest analysis for Edgewell Personal Care. At a share price of $21.56, Edgewell Personal Care has seen a 1 month share price return of 2.76% and a year to date share price return of 27.88%. However, the 1 year total shareholder return of 27.66%...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Mueller Industries, Inc. ( NYSE:MLI ) announced strong profits, but the stock was stagnant. Our analysis suggests that...

The market for United Parcel Service, Inc.'s ( NYSE:UPS ) shares didn't move much after it posted weak earnings...

Shareholders appeared unconcerned with Kimberly-Clark Corporation's ( NASDAQ:KMB ) lackluster earnings report last...

We note that the The Western Union Company ( NYSE:WU ) President of Europe, Giovanni Angelini, recently sold US$57k...